ArticleFrontiers in endocrinology2025

Bioinformatics analysis combined with experimental validation reveals the novel mechanisms of multi-targets of dapagliflozin attenuating diabetic liver injury.

Pengyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.